Background Taiwan is endemic for pyogenic liver abscess (PLA). Septic ocular or central nervous system (CNS) complications derived from PLA can result in catastrophic disability. We investigated the epidemiology and long-term prognosis of PLA patients with septic ocular or CNS complications over an 8-year period. Methodology/Principal Findings We extracted 21,307 patients with newly diagnosed PLA from a nationwide health registry in Taiwan between 2000 and 2007. The frequency of and risk factors for PLA with septic ocular or CNS complications were determined. The 2-year survival of these patients was compared between those with and without septic ocular or CNS complications. Septic ocular or CNS complications accounted for 2.1% of all PLA patients. Age and the Charlson comorbidity index were significantly lower in PLA patients with ocular or CNS complications than those without. Diabetes and age <65 years were independent predictors of septic ocular or CNS complications. The 2-year mortality of patients with septic ocular or CNS complications was similar to those without complications (24.8% vs. 27.5%, p = 0.502). However, among patients <65 years old and a Charlson index ≤1, the 2-year mortality was significantly higher in those with than without complications (18.6% vs. 11.8%, p = 0.001). Conclusions/Significance Physicians should recognize that catastrophic disability due to ocular or neurological complications from PLA could lead to a poor long-term prognosis, and should follow-up these patients more closely.
References
[1]
Kaplan GG, Gregson DB, Laupland KB (2004) Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol 2: 1032–1038.
[2]
Meddings L, Myers RP, Hubbard J, Shaheen AA, Laupland KB, et al. (2010) A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol 105: 117–124.
[3]
Jepsen P, Vilstrup H, Sch？nheyder HC, S？rensen HT (2005) A nationwide study of the incidence and 30-day mortality rate of pyogenic liver abscess in Denmark, 1977–2002. Aliment Pharmacol Ther 21: 1185–1188.
[4]
Tsai FC, Huang YT, Chang LY, Wang JT (2008) Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis 14: 1592–1600.
[5]
Lederman ER, Crum NF (2005) Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol 100: 322–331.
[6]
Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS (1991) Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 151: 1557–1559.
[7]
Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, et al. (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26: 1434–1438.
[8]
Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, et al. (2002) A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50: 420–424.
[9]
Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, et al. (2002) Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8: 160–166.
[10]
Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, et al. (2007) Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 54: 578–583.
[11]
Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, et al. (2007) Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45: 284–293.
[12]
Yeh KM, Kurup A, Siu LK, Koh YL, Fung CP, et al. (2007) Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 45: 466–471.
[13]
Lok KH, Li KF, Li KK, Szeto ML (2008) Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital. J Microbiol Immunol Infect 41: 483–490.
[14]
Liu YC, Cheng DL, Lin CL (1986) Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 146: 1913–1916.
[15]
Chou FF, Kou HK (1996) Endogenous endophthalmitis associated with pyogenic hepatic abscess. J Am Coll Surg 182: 33–36.
[16]
Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, et al. (2007) Endogenous Klebsiella endophthalmitis associated with pyogenic liver Abscess. Ophthalmology 114: 876–880.
[17]
Lee SS, Chen YS, Tsai HC, Wann SR, Lin HH, et al. (2008) Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess. Clin Infect Dis 47: 642–650.
[18]
Sheu SJ, Kung YH, Wu TT, Chang FP, Horng YH (2011) Risk factors for endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess: 20-year experience in southern Taiwan. Retina 31: 2026–2031.
[19]
Tan YM, Chee SP, Soo KC, Chow P (2004) Ocular manifestations and complications of pyogenic liver abscess. World J Surg 28: 38–42.
[20]
Lin YT, Liu CJ, Chen TJ, Chen TL, Yeh YC, et al. (2011) Pyogenic liver abscess as the initial manefestation of underlying hepatocellular carcinoma. Am J Med 124: 1158–1164.
[21]
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373–383.
[22]
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613–619.
[23]
Al-Mahmood A, Al-Binali G, AlKatan H, Abboud E, Abu El-Asrar A (2011) Endogenous endophthalmitis associated with liver abscess caused by Klebsiella pneumoniae. Int Ophthalmol 31: 145–148.
[24]
Laupland KB, Svenson LW, Gregson DB, Church DL (2011) Long-term mortality associated with community-onset bloodstream infection. Infection 39: 405–410.
[25]
Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, et al. (1995) Long-term survival following bacteremia or fungemia. JAMA 274: 807–812.
